Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 20-Feb-24 9:21 PM View:  | Spyre Therapeutics, Inc. (SYRE) | 15-Feb-24 | Grant | 400 | $9.82 | $3,928.00 | < 1% 746.51K to 746.91K | |
| 27-Nov-23 4:25 PM View: | Spyre Therapeutics, Inc. (SYRE) | 24-Nov-23 | Conversion | 723,440 | -- | -- | 3136% 23.07K to 746.51K | |
| 28-Jan-21 7:15 PM View: | Eidos Therapeutics, Inc. (EIDX) | 26-Jan-21 | Disposition (change in control) | 50,699 | -- | -- | (100%) 50.7K to 0 | |
| 29-Dec-20 9:14 PM View: | Bridgebio Pharma, Inc. (BBIO) | 28-Dec-20 | Option Exercise | 19,500 | $6.69 | $130,500.00 | 155% 12.57K to 32.07K | |
| 29-Dec-20 9:14 PM View: | Bridgebio Pharma, Inc. (BBIO) | 28-Dec-20 | Market Option Sale (Planned) | 19,500 | $69.60 | $1,357,180.00 | (61%) 32.07K to 12.57K | |
| 16-Dec-20 7:27 PM View: | Eidos Therapeutics, Inc. (EIDX) | 15-Dec-20 | Option Exercise | 26,294 | $13.84 | $363,995.00 | 52% 50.62K to 76.92K | |
| 16-Dec-20 7:27 PM View: | Eidos Therapeutics, Inc. (EIDX) | 15-Dec-20 | Market Option Sale | 26,294 | $111.77 | $2,938,800.00 | (34%) 76.92K to 50.62K | (15%) |
| 25-Nov-20 9:54 PM View: | Bridgebio Pharma, Inc. (BBIO) | 25-Nov-20 | Option Exercise | 742 | $17.00 | $12,614.00 | 6% 12.57K to 13.31K | |
| 25-Nov-20 9:54 PM View: | Bridgebio Pharma, Inc. (BBIO) | 25-Nov-20 | Planned Option Sale | 742 | $47.23 | $35,043.80 | (6%) 13.31K to 12.57K | |
| 25-Nov-20 9:54 PM View: | Bridgebio Pharma, Inc. (BBIO) | 24-Nov-20 | Option Exercise | 4,258 | $17.00 | $72,386.00 | 34% 12.57K to 16.83K | |
| 25-Nov-20 9:54 PM View: | Bridgebio Pharma, Inc. (BBIO) | 24-Nov-20 | Planned Option Sale | 4,258 | $47.00 | $200,137.00 | (25%) 16.83K to 12.57K | |
| 13-Nov-20 5:00 PM View: | Eidos Therapeutics, Inc. (EIDX) | 11-Nov-20 | Gift | 1,500 | -- | -- | (2%) 65.53K to 64.03K | |
| 13-Nov-20 5:00 PM View: | Eidos Therapeutics, Inc. (EIDX) | 11-Nov-20 | Market Sale | 13,410 | $74.51 | $999,227.00 | (21%) 64.03K to 50.62K | (72%) |
| 09-Nov-20 4:05 PM View: | Bridgebio Pharma, Inc. (BBIO) | 05-Nov-20 | Option Exercise | 2,500 | $17.00 | $42,500.00 | 20% 12.57K to 15.07K | |
| 09-Nov-20 4:05 PM View: | Bridgebio Pharma, Inc. (BBIO) | 05-Nov-20 | Planned Option Sale | 2,500 | $42.05 | $105,125.00 | (17%) 15.07K to 12.57K | |
| 03-Nov-20 4:05 PM View: | Eidos Therapeutics, Inc. (EIDX) | 02-Nov-20 | Option Exercise | 7,500 | $14.47 | $108,500.00 | 11% 70.53K to 78.03K | |
| 03-Nov-20 4:05 PM View: | Eidos Therapeutics, Inc. (EIDX) | 02-Nov-20 | Market Option Sale (Planned) | 7,500 | $70.72 | $530,372.00 | (10%) 78.03K to 70.53K | (82%) |
| 03-Nov-20 4:05 PM View: | Eidos Therapeutics, Inc. (EIDX) | 02-Nov-20 | Market Sale (Planned) | 5,000 | $70.72 | $353,581.00 | (7%) 70.53K to 65.53K | (82%) |
| 02-Oct-20 7:57 PM View: | Bridgebio Pharma, Inc. (BBIO) | 30-Sep-20 | Option Exercise | 14,500 | $3.14 | $45,500.00 | 115% 12.57K to 27.07K | |
| 02-Oct-20 7:57 PM View: | Bridgebio Pharma, Inc. (BBIO) | 30-Sep-20 | Planned Option Sale | 14,500 | $37.69 | $546,458.00 | (54%) 27.07K to 12.57K | |
| 22-Sep-20 7:07 PM View: | Bridgebio Pharma, Inc. (BBIO) | 18-Sep-20 | Option Exercise | 2,500 | $17.00 | $42,500.00 | 20% 12.57K to 15.07K | |
| 22-Sep-20 7:07 PM View: | Bridgebio Pharma, Inc. (BBIO) | 18-Sep-20 | Planned Option Sale | 2,500 | $42.01 | $105,024.00 | (17%) 15.07K to 12.57K | |
| 16-Sep-20 6:38 PM View: | Bridgebio Pharma, Inc. (BBIO) | 15-Sep-20 | Option Exercise | 2,500 | $17.00 | $42,500.00 | 20% 12.57K to 15.07K | |
| 16-Sep-20 6:38 PM View: | Bridgebio Pharma, Inc. (BBIO) | 15-Sep-20 | Planned Option Sale | 2,500 | $37.06 | $92,651.80 | (17%) 15.07K to 12.57K | |
| 15-Sep-20 4:05 PM View: | Bridgebio Pharma, Inc. (BBIO) | 11-Sep-20 | Option Exercise | 2,000 | $0.34 | $680.00 | 16% 12.57K to 14.57K | |
| 15-Sep-20 4:05 PM View: | Bridgebio Pharma, Inc. (BBIO) | 11-Sep-20 | Planned Option Sale | 2,000 | $35.02 | $70,047.00 | (14%) 14.57K to 12.57K | |
| 11-Sep-20 4:05 PM View: | Eidos Therapeutics, Inc. (EIDX) | 10-Sep-20 | Option Exercise | 2,500 | $17.00 | $42,500.00 | 4% 70.53K to 73.03K | |
| 11-Sep-20 4:05 PM View: | Eidos Therapeutics, Inc. (EIDX) | 10-Sep-20 | Market Option Sale (Planned) | 2,500 | $47.00 | $117,500.00 | (3%) 73.03K to 70.53K | (173%) |
| 02-Sep-20 4:05 PM View: | Bridgebio Pharma, Inc. (BBIO) | 01-Sep-20 | Grant | 2,745 | -- | -- | 28% 9.82K to 12.57K | |
| 05-Aug-20 7:45 PM View: | Eidos Therapeutics, Inc. (EIDX) | 03-Aug-20 | Option Exercise | 5,000 | $13.20 | $66,000.00 | 7% 75.53K to 80.53K | |
| 05-Aug-20 7:45 PM View: | Eidos Therapeutics, Inc. (EIDX) | 03-Aug-20 | Market Option Sale (Planned) | 5,000 | $39.94 | $199,725.00 | (6%) 80.53K to 75.53K | (222%) |
| 05-Aug-20 7:45 PM View: | Eidos Therapeutics, Inc. (EIDX) | 03-Aug-20 | Market Sale (Planned) | 5,000 | $39.94 | $199,725.00 | (7%) 75.53K to 70.53K | (222%) |
| 02-Jul-20 4:28 PM View: | Bridgebio Pharma, Inc. (BBIO) | 30-Jun-20 | Option Exercise | 10,000 | $0.23 | $2,320.00 | 102% 9.82K to 19.82K | |
| 02-Jul-20 4:28 PM View: | Bridgebio Pharma, Inc. (BBIO) | 30-Jun-20 | Option Sale | 10,000 | $32.66 | $326,623.00 | (50%) 19.82K to 9.82K | |
| 05-Jun-20 4:06 PM View: | Eidos Therapeutics, Inc. (EIDX) | 31-May-20 | Grant | 376 | $41.57 | $15,631.60 | < 1% 75.16K to 75.53K | |
| 28-May-20 4:05 PM View: | Eidos Therapeutics, Inc. (EIDX) | 26-May-20 | Option Exercise | 2,500 | $17.00 | $42,500.00 | 3% 75.16K to 77.66K | |
| 28-May-20 4:05 PM View: | Eidos Therapeutics, Inc. (EIDX) | 26-May-20 | Market Option Sale (Planned) | 2,500 | $47.00 | $117,500.00 | (3%) 77.66K to 75.16K | (173%) |
| 05-May-20 4:26 PM View: | Eidos Therapeutics, Inc. (EIDX) | 01-May-20 | Option Exercise | 5,000 | $13.20 | $66,000.00 | 6% 80.16K to 85.16K | |
| 05-May-20 4:26 PM View: | Eidos Therapeutics, Inc. (EIDX) | 01-May-20 | Market Option Sale (Planned) | 5,000 | $40.84 | $204,217.00 | (6%) 85.16K to 80.16K | (214%) |
| 05-May-20 4:26 PM View: | Eidos Therapeutics, Inc. (EIDX) | 01-May-20 | Market Sale (Planned) | 5,000 | $40.84 | $204,217.00 | (6%) 80.16K to 75.16K | (214%) |
| 29-Apr-20 4:05 PM View: | Bridgebio Pharma, Inc. (BBIO) | 27-Apr-20 | Option Exercise | 2,000 | $17.00 | $34,000.00 | 20% 9.82K to 11.82K | |
| 29-Apr-20 4:05 PM View: | Bridgebio Pharma, Inc. (BBIO) | 27-Apr-20 | Planned Option Sale | 2,000 | $32.01 | $64,027.60 | (17%) 11.82K to 9.82K | |
| 10-Apr-20 8:22 AM View: | Bridgebio Pharma, Inc. (BBIO) | 08-Apr-20 | Option Exercise | 8,000 | $17.00 | $136,000.00 | 81% 9.82K to 17.82K | |
| 10-Apr-20 8:22 AM View: | Bridgebio Pharma, Inc. (BBIO) | 08-Apr-20 | Planned Option Sale | 8,000 | $27.04 | $216,358.00 | (45%) 17.82K to 9.82K | |
| 13-Feb-20 8:48 PM View: | Bridgebio Pharma, Inc. (BBIO) | 11-Feb-20 | Option Exercise | 2,000 | $17.00 | $34,000.00 | 20% 9.82K to 11.82K | |
| 13-Feb-20 8:48 PM View: | Bridgebio Pharma, Inc. (BBIO) | 11-Feb-20 | Planned Option Sale | 2,000 | $37.28 | $74,564.20 | (17%) 11.82K to 9.82K | |
| 05-Feb-20 4:05 PM View: | Eidos Therapeutics, Inc. (EIDX) | 03-Feb-20 | Option Exercise | 7,500 | $14.47 | $108,500.00 | 9% 85.16K to 92.66K | |
| 05-Feb-20 4:05 PM View: | Eidos Therapeutics, Inc. (EIDX) | 03-Feb-20 | Market Option Sale (Planned) | 7,500 | $53.65 | $402,384.00 | (8%) 92.66K to 85.16K | (139%) |
| 05-Feb-20 4:05 PM View: | Eidos Therapeutics, Inc. (EIDX) | 03-Feb-20 | Market Sale (Planned) | 5,000 | $53.65 | $268,256.00 | (6%) 85.16K to 80.16K | (139%) |
| 10-Jan-20 5:15 PM View: | Bridgebio Pharma, Inc. (BBIO) | 08-Jan-20 | Option Exercise | 10,000 | $17.00 | $170,000.00 | 79% 12.63K to 22.63K |